It has been my, perhaps fantasy assumption, that RCPIQ's Chapter 7 bankruptcy application was a strategy to stop the hemorrhaging of shares resulting from a failed loan arrangement. That fantasy imagines that RCPIQ had made an arrangement with the lender under which it would become a "shell" into which MYMD Pharmaceutical would reverse merge. It would then issue MYMD shares for the shares of RCPIQ held by the lender, thereby converting the existing debt into a stock position in MYMD Pharma.
My preferred arrangement would be for MYMD to authorize 17.04 million shares, and issue to RCPIQ shareholders 1 share of its stock for each 10 shares of RCPIQ stock.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.